| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 JAG1 STAB1 | 6.63e-15 | 749 | 38 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | Notch binding | 9.02e-12 | 27 | 38 | 6 | GO:0005112 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.18e-11 | 188 | 38 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.38e-06 | 12 | 38 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.28e-06 | 14 | 38 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.50e-06 | 16 | 38 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.50e-06 | 891 | 38 | 10 | GO:0005198 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 8.26e-06 | 21 | 38 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 6.72e-05 | 547 | 38 | 7 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 7.28e-05 | 554 | 38 | 7 | GO:0030546 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 7.48e-05 | 1233 | 38 | 10 | GO:0140677 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 1.41e-04 | 616 | 38 | 7 | GO:0030545 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.47e-04 | 268 | 38 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | integrin binding | 3.33e-04 | 175 | 38 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | heparin binding | 4.74e-04 | 192 | 38 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 5.29e-04 | 18 | 38 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 5.64e-04 | 85 | 38 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.02e-03 | 35 | 38 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.02e-03 | 35 | 38 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | fibronectin binding | 2.37e-03 | 38 | 38 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.22e-03 | 323 | 38 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.29e-03 | 599 | 38 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 5.60e-03 | 190 | 38 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 7.09e-03 | 207 | 38 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | RNA methyltransferase activity | 7.21e-03 | 67 | 38 | 2 | GO:0008173 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 7.57e-03 | 212 | 38 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | peptidase activity | 7.62e-03 | 654 | 38 | 5 | GO:0008233 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 4.34e-08 | 53 | 38 | 5 | GO:0045747 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 5.97e-08 | 114 | 38 | 6 | GO:0008593 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 1.15e-07 | 6 | 38 | 3 | GO:0060120 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 1.15e-07 | 6 | 38 | 3 | GO:0009912 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 1.15e-07 | 6 | 38 | 3 | GO:0002085 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 7.07e-07 | 92 | 38 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 7.69e-07 | 39 | 38 | 4 | GO:0003180 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 1.02e-06 | 99 | 38 | 5 | GO:0045995 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.51e-06 | 46 | 38 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 2.12e-06 | 50 | 38 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 2.18e-06 | 210 | 38 | 6 | GO:0007219 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.43e-06 | 338 | 38 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 2.59e-06 | 15 | 38 | 3 | GO:0048505 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 3.61e-06 | 57 | 38 | 4 | GO:0061383 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 3.85e-06 | 17 | 38 | 3 | GO:0040034 | |
| GeneOntologyBiologicalProcess | artery development | 4.37e-06 | 133 | 38 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 5.40e-06 | 63 | 38 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | embryo development | JAG2 LRP4 FBN2 TENM4 DLL1 DLL4 LRP1B ST14 NOTCH1 PCSK6 JAG1 LAMA1 | 6.16e-06 | 1437 | 38 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | inner ear auditory receptor cell differentiation | 6.91e-06 | 67 | 38 | 4 | GO:0042491 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.91e-06 | 412 | 38 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.03e-05 | 74 | 38 | 4 | GO:0002011 | |
| GeneOntologyBiologicalProcess | cellular response to vascular endothelial growth factor stimulus | 1.14e-05 | 76 | 38 | 4 | GO:0035924 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.27e-05 | 78 | 38 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 1.27e-05 | 78 | 38 | 4 | GO:0035315 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.33e-05 | 817 | 38 | 9 | GO:0048514 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.47e-05 | 445 | 38 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.82e-05 | 850 | 38 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.98e-05 | 4 | 38 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 2.06e-05 | 1095 | 38 | 10 | GO:0060284 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 2.33e-05 | 91 | 38 | 4 | GO:0048663 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.45e-05 | 482 | 38 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.47e-05 | 883 | 38 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.61e-05 | 1125 | 38 | 10 | GO:0035239 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 2.88e-05 | 96 | 38 | 4 | GO:0060113 | |
| GeneOntologyBiologicalProcess | tube development | FBN1 COMP DLL1 DLL4 LDLR EMILIN1 ST14 NOTCH1 JAG1 LAMA1 STAB1 | 2.99e-05 | 1402 | 38 | 11 | GO:0035295 |
| GeneOntologyBiologicalProcess | negative regulation of inner ear receptor cell differentiation | 3.29e-05 | 5 | 38 | 2 | GO:2000981 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 3.29e-05 | 5 | 38 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear auditory receptor cell differentiation | 3.29e-05 | 5 | 38 | 2 | GO:0045608 | |
| GeneOntologyBiologicalProcess | negative regulation of mechanoreceptor differentiation | 3.29e-05 | 5 | 38 | 2 | GO:0045632 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 3.61e-05 | 927 | 38 | 9 | GO:0030155 | |
| GeneOntologyBiologicalProcess | blood vessel development | 3.67e-05 | 929 | 38 | 9 | GO:0001568 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.81e-05 | 347 | 38 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 3.82e-05 | 713 | 38 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | circulatory system development | FBN1 TENM4 COMP DLL1 DLL4 LDLR EMILIN1 NOTCH1 JAG1 LAMA1 STAB1 | 3.88e-05 | 1442 | 38 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 3.95e-05 | 104 | 38 | 4 | GO:0042490 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 4.93e-05 | 6 | 38 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | vasculature development | 5.11e-05 | 969 | 38 | 9 | GO:0001944 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | LRP4 FBLN1 FBN1 DLL1 DLL4 IL23A LDLR EMILIN1 NOTCH1 FGL2 STAB1 | 5.18e-05 | 1488 | 38 | 11 | GO:0051241 |
| GeneOntologyBiologicalProcess | skin development | 5.69e-05 | 373 | 38 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 5.86e-05 | 41 | 38 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 6.03e-05 | 377 | 38 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 6.12e-05 | 378 | 38 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 6.21e-05 | 379 | 38 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of somitogenesis | 6.90e-05 | 7 | 38 | 2 | GO:0014807 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 7.26e-05 | 1269 | 38 | 10 | GO:0009887 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 9.19e-05 | 8 | 38 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 9.19e-05 | 8 | 38 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | negative regulation of Notch signaling pathway | 9.42e-05 | 48 | 38 | 3 | GO:0045746 | |
| GeneOntologyBiologicalProcess | organ growth | 1.02e-04 | 256 | 38 | 5 | GO:0035265 | |
| GeneOntologyBiologicalProcess | cell fate determination | 1.07e-04 | 50 | 38 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | neuroepithelial cell differentiation | 1.13e-04 | 51 | 38 | 3 | GO:0060563 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 1.18e-04 | 9 | 38 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 1.18e-04 | 9 | 38 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.19e-04 | 619 | 38 | 7 | GO:0002009 | |
| GeneOntologyBiologicalProcess | loop of Henle development | 1.47e-04 | 10 | 38 | 2 | GO:0072070 | |
| GeneOntologyBiologicalProcess | distal tubule development | 1.47e-04 | 10 | 38 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 1.51e-04 | 147 | 38 | 4 | GO:0030278 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.65e-04 | 284 | 38 | 5 | GO:0009913 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.80e-04 | 11 | 38 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | epidermis development | 1.82e-04 | 461 | 38 | 6 | GO:0008544 | |
| GeneOntologyBiologicalProcess | regulation of inner ear receptor cell differentiation | 2.16e-04 | 12 | 38 | 2 | GO:2000980 | |
| GeneOntologyBiologicalProcess | regulation of memory T cell differentiation | 2.16e-04 | 12 | 38 | 2 | GO:0043380 | |
| GeneOntologyBiologicalProcess | regulation of inner ear auditory receptor cell differentiation | 2.16e-04 | 12 | 38 | 2 | GO:0045607 | |
| GeneOntologyBiologicalProcess | regulation of mechanoreceptor differentiation | 2.16e-04 | 12 | 38 | 2 | GO:0045631 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 2.39e-04 | 1186 | 38 | 9 | GO:0007167 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 2.55e-04 | 13 | 38 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 2.55e-04 | 13 | 38 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | memory T cell differentiation | 2.55e-04 | 13 | 38 | 2 | GO:0043379 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 2.63e-04 | 1483 | 38 | 10 | GO:0048646 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 2.78e-04 | 69 | 38 | 3 | GO:0030857 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 2.79e-04 | 1211 | 38 | 9 | GO:0030334 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 2.95e-04 | 1220 | 38 | 9 | GO:0051093 | |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 2.97e-04 | 14 | 38 | 2 | GO:0062042 | |
| GeneOntologyBiologicalProcess | bone trabecula formation | 2.97e-04 | 14 | 38 | 2 | GO:0060346 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 2.97e-04 | 14 | 38 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | immunological memory formation process | 2.97e-04 | 14 | 38 | 2 | GO:0090715 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 3.29e-04 | 515 | 38 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 3.42e-04 | 74 | 38 | 3 | GO:0010812 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell development | 3.42e-04 | 15 | 38 | 2 | GO:0097084 | |
| GeneOntologyBiologicalProcess | blood vessel endothelial cell differentiation | 3.42e-04 | 15 | 38 | 2 | GO:0060837 | |
| GeneOntologyBiologicalProcess | endothelium development | 3.42e-04 | 182 | 38 | 4 | GO:0003158 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 3.85e-04 | 750 | 38 | 7 | GO:0048729 | |
| GeneOntologyBiologicalProcess | neuroendocrine cell differentiation | 3.90e-04 | 16 | 38 | 2 | GO:0061101 | |
| GeneOntologyBiologicalProcess | negative regulation of epidermis development | 3.90e-04 | 16 | 38 | 2 | GO:0045683 | |
| GeneOntologyBiologicalProcess | negative regulation of epidermal cell differentiation | 3.90e-04 | 16 | 38 | 2 | GO:0045605 | |
| GeneOntologyBiologicalProcess | heart development | 4.07e-04 | 757 | 38 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 4.19e-04 | 192 | 38 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 4.20e-04 | 1280 | 38 | 9 | GO:2000145 | |
| GeneOntologyBiologicalProcess | aorta development | 4.30e-04 | 80 | 38 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 4.42e-04 | 17 | 38 | 2 | GO:0003222 | |
| GeneOntologyCellularComponent | extracellular matrix | FBLN1 THBS3 FBN1 FBN2 FCGBP COMP MEGF6 ADAMTSL3 SSPOP EMILIN1 PCSK6 FGL2 LAMA1 | 6.69e-11 | 656 | 38 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FBLN1 THBS3 FBN1 FBN2 FCGBP COMP MEGF6 ADAMTSL3 SSPOP EMILIN1 PCSK6 FGL2 LAMA1 | 6.95e-11 | 658 | 38 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 SSPOP EMILIN1 PCSK6 FGL2 LAMA1 | 1.63e-09 | 530 | 38 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 2.48e-04 | 13 | 38 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.30e-04 | 17 | 38 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | basement membrane | 1.41e-03 | 122 | 38 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.16e-03 | 59 | 38 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | adherens junction | 6.68e-03 | 212 | 38 | 3 | GO:0005912 | |
| HumanPheno | Abnormal upper to lower segment ratio | 3.14e-05 | 3 | 17 | 2 | HP:0012772 | |
| HumanPheno | Abnormality of the metacarpal bones | 6.15e-05 | 228 | 17 | 6 | HP:0001163 | |
| HumanPheno | Abnormal metacarpal morphology | 6.15e-05 | 228 | 17 | 6 | HP:0005916 | |
| HumanPheno | Ascending aortic dissection | 7.66e-05 | 26 | 17 | 3 | HP:0004933 | |
| HumanPheno | Abnormal ascending aorta morphology | 8.60e-05 | 27 | 17 | 3 | HP:0031784 | |
| HumanPheno | Abnormal aortic morphology | 9.16e-05 | 363 | 17 | 7 | HP:0030963 | |
| HumanPheno | Crumpled ear | 1.56e-04 | 6 | 17 | 2 | HP:0009901 | |
| HumanPheno | Abnormal aortic morphology | 1.73e-04 | 401 | 17 | 7 | HP:0001679 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 1.95e-04 | 174 | 17 | 5 | HP:0009832 | |
| HumanPheno | Abnormality of the musculature of the upper limbs | 2.05e-04 | 283 | 17 | 6 | HP:0001446 | |
| HumanPheno | Cardiovascular calcification | 2.62e-04 | 39 | 17 | 3 | HP:0011915 | |
| HumanPheno | Heart murmur | 2.62e-04 | 39 | 17 | 3 | HP:0030148 | |
| HumanPheno | Aortic dissection | 2.83e-04 | 40 | 17 | 3 | HP:0002647 | |
| HumanPheno | Absent fingernail | 2.83e-04 | 40 | 17 | 3 | HP:0001817 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | 2.92e-04 | 436 | 17 | 7 | HP:0040065 | |
| HumanPheno | Abnormal heart sound | 3.27e-04 | 42 | 17 | 3 | HP:0031657 | |
| HumanPheno | Short finger | 4.37e-04 | 325 | 17 | 6 | HP:0009381 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 5.22e-04 | 215 | 17 | 5 | HP:0031650 | |
| HumanPheno | Short distal phalanx of finger | 5.33e-04 | 119 | 17 | 4 | HP:0009882 | |
| HumanPheno | Abnormal upper limb bone morphology | 5.58e-04 | 484 | 17 | 7 | HP:0040070 | |
| HumanPheno | Foot oligodactyly | 5.67e-04 | 11 | 17 | 2 | HP:0001849 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanges of the hand | 6.23e-04 | 124 | 17 | 4 | HP:0009835 | |
| HumanPheno | Abnormality of the musculature of the hand | 6.42e-04 | 125 | 17 | 4 | HP:0001421 | |
| MousePheno | fused phalanges | 7.87e-06 | 16 | 35 | 3 | MP:0008730 | |
| MousePheno | increased cochlear hair cell number | 1.59e-05 | 20 | 35 | 3 | MP:0004407 | |
| MousePheno | increased neuron number | 3.00e-05 | 72 | 35 | 4 | MP:0008947 | |
| MousePheno | thick apical ectodermal ridge | 3.64e-05 | 4 | 35 | 2 | MP:0001678 | |
| MousePheno | abnormal phalanx morphology | 3.72e-05 | 76 | 35 | 4 | MP:0005306 | |
| MousePheno | abnormal capillary morphology | 8.21e-05 | 93 | 35 | 4 | MP:0003658 | |
| MousePheno | abnormal artery morphology | 9.14e-05 | 440 | 35 | 7 | MP:0002191 | |
| MousePheno | abnormal vertebral column morphology | 1.02e-04 | 787 | 35 | 9 | MP:0004703 | |
| MousePheno | increased sensory neuron number | 1.44e-04 | 41 | 35 | 3 | MP:0006006 | |
| MousePheno | decreased circulating unsaturated transferrin level | 1.69e-04 | 8 | 35 | 2 | MP:0011897 | |
| MousePheno | abnormal aorta morphology | 2.26e-04 | 225 | 35 | 5 | MP:0000272 | |
| MousePheno | abnormal cochlear outer hair cell number | 2.60e-04 | 50 | 35 | 3 | MP:0004400 | |
| MousePheno | abnormal heart atrium morphology | 2.61e-04 | 232 | 35 | 5 | MP:0003105 | |
| MousePheno | decreased circulating transferrin level | 2.71e-04 | 10 | 35 | 2 | MP:0011894 | |
| MousePheno | abnormal appendicular skeleton morphology | 2.72e-04 | 896 | 35 | 9 | MP:0009250 | |
| MousePheno | abnormal embryonic tissue morphology | 2.92e-04 | 1116 | 35 | 10 | MP:0002085 | |
| MousePheno | abnormal apoptosis | 3.13e-04 | 1353 | 35 | 11 | MP:0001648 | |
| MousePheno | abnormal programmed cell death | 3.27e-04 | 1360 | 35 | 11 | MP:0014355 | |
| MousePheno | internal hemorrhage | 3.56e-04 | 387 | 35 | 6 | MP:0001634 | |
| MousePheno | increased T cell apoptosis | 3.83e-04 | 57 | 35 | 3 | MP:0006413 | |
| MousePheno | abnormal limb development | 3.96e-04 | 140 | 35 | 4 | MP:0006279 | |
| MousePheno | abnormal limb long bone morphology | 4.39e-04 | 568 | 35 | 7 | MP:0011504 | |
| MousePheno | abnormal limb bone morphology | 5.35e-04 | 587 | 35 | 7 | MP:0002115 | |
| MousePheno | increased cochlear inner hair cell number | 5.44e-04 | 14 | 35 | 2 | MP:0004395 | |
| MousePheno | abnormal axial skeleton morphology | JAG2 LRP4 FBLN1 FBN1 FBN2 TENM4 DLL1 ADAMTSL3 SSPOP NOTCH1 PCSK6 | 5.97e-04 | 1458 | 35 | 11 | MP:0002114 |
| MousePheno | cornea opacity | 6.41e-04 | 159 | 35 | 4 | MP:0001314 | |
| MousePheno | abnormal cochlear hair cell number | 6.45e-04 | 68 | 35 | 3 | MP:0004406 | |
| MousePheno | abnormal germ layer morphology | 6.72e-04 | 161 | 35 | 4 | MP:0014138 | |
| MousePheno | increased cochlear outer hair cell number | 7.15e-04 | 16 | 35 | 2 | MP:0004401 | |
| MousePheno | ventricle myocardium hypoplasia | 7.31e-04 | 71 | 35 | 3 | MP:0010502 | |
| MousePheno | abnormal somatic nervous system morphology | 7.32e-04 | 1025 | 35 | 9 | MP:0002752 | |
| MousePheno | aorta stenosis | 8.09e-04 | 17 | 35 | 2 | MP:0010463 | |
| MousePheno | abnormal systemic artery morphology | 8.94e-04 | 304 | 35 | 5 | MP:0011655 | |
| MousePheno | abnormal blood circulation | 9.41e-04 | 845 | 35 | 8 | MP:0002128 | |
| Domain | EGF | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 FCGBP TENM4 COMP MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 PCSK6 JAG1 LAMA1 STAB1 | 1.20e-30 | 235 | 38 | 21 | SM00181 |
| Domain | EGF-like_dom | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 FCGBP TENM4 COMP MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 PCSK6 JAG1 LAMA1 STAB1 | 4.20e-30 | 249 | 38 | 21 | IPR000742 |
| Domain | EGF_CA | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 JAG1 STAB1 | 5.78e-28 | 122 | 38 | 17 | SM00179 |
| Domain | EGF_1 | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 TENM4 COMP MEGF6 DLL1 DLL4 SSPOP LRP1B LDLR F10 NOTCH1 JAG1 LAMA1 STAB1 | 6.44e-28 | 255 | 38 | 20 | PS00022 |
| Domain | EGF-like_Ca-bd_dom | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 JAG1 STAB1 | 7.76e-28 | 124 | 38 | 17 | IPR001881 |
| Domain | EGF_2 | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 TENM4 COMP MEGF6 DLL1 DLL4 SSPOP LRP1B LDLR F10 NOTCH1 JAG1 LAMA1 STAB1 | 1.42e-27 | 265 | 38 | 20 | PS01186 |
| Domain | EGF_3 | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 TENM4 COMP MEGF6 DLL1 DLL4 SSPOP LRP1B LDLR F10 NOTCH1 JAG1 STAB1 | 1.08e-26 | 235 | 38 | 19 | PS50026 |
| Domain | Growth_fac_rcpt_ | JAG2 LRP4 FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 DLL1 DLL4 LRP1B LDLR NOTCH1 PCSK6 JAG1 LAMA1 STAB1 | 4.74e-26 | 156 | 38 | 17 | IPR009030 |
| Domain | EGF-like_CS | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 TENM4 COMP MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 JAG1 LAMA1 STAB1 | 8.31e-26 | 261 | 38 | 19 | IPR013032 |
| Domain | EGF_Ca-bd_CS | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 DLL1 LRP1B LDLR F10 NOTCH1 JAG1 | 2.44e-25 | 97 | 38 | 15 | IPR018097 |
| Domain | EGF_CA | JAG2 DLK2 LRP4 FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 DLL1 LRP1B LDLR F10 NOTCH1 JAG1 | 3.39e-25 | 99 | 38 | 15 | PS01187 |
| Domain | ASX_HYDROXYL | JAG2 DLK2 LRP4 FBLN1 FBN1 FBN2 MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 JAG1 | 5.37e-23 | 100 | 38 | 14 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | JAG2 DLK2 LRP4 FBLN1 FBN1 FBN2 MEGF6 DLL1 DLL4 LRP1B LDLR F10 NOTCH1 JAG1 | 1.28e-22 | 106 | 38 | 14 | IPR000152 |
| Domain | EGF_CA | JAG2 LRP4 FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 LRP1B LDLR NOTCH1 JAG1 | 1.00e-19 | 86 | 38 | 12 | PF07645 |
| Domain | EGF | 8.71e-16 | 126 | 38 | 11 | PF00008 | |
| Domain | EGF_extracell | 2.95e-15 | 60 | 38 | 9 | IPR013111 | |
| Domain | EGF_2 | 2.95e-15 | 60 | 38 | 9 | PF07974 | |
| Domain | hEGF | 9.22e-14 | 28 | 38 | 7 | PF12661 | |
| Domain | DSL | 1.46e-11 | 4 | 38 | 4 | PF01414 | |
| Domain | DSL | 1.46e-11 | 4 | 38 | 4 | SM00051 | |
| Domain | DSL | 7.27e-11 | 5 | 38 | 4 | IPR001774 | |
| Domain | DSL | 7.27e-11 | 5 | 38 | 4 | PS51051 | |
| Domain | Notch_ligand_N | 7.27e-11 | 5 | 38 | 4 | IPR011651 | |
| Domain | MNNL | 7.27e-11 | 5 | 38 | 4 | PF07657 | |
| Domain | cEGF | 1.69e-09 | 26 | 38 | 5 | IPR026823 | |
| Domain | cEGF | 1.69e-09 | 26 | 38 | 5 | PF12662 | |
| Domain | LDLR_class-A_CS | 1.66e-08 | 40 | 38 | 5 | IPR023415 | |
| Domain | Ldl_recept_a | 3.05e-08 | 45 | 38 | 5 | PF00057 | |
| Domain | - | 3.42e-08 | 46 | 38 | 5 | 4.10.400.10 | |
| Domain | LDLRA_1 | 4.26e-08 | 48 | 38 | 5 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.74e-08 | 49 | 38 | 5 | IPR002172 | |
| Domain | LDLa | 4.74e-08 | 49 | 38 | 5 | SM00192 | |
| Domain | LDLRA_2 | 4.74e-08 | 49 | 38 | 5 | PS50068 | |
| Domain | VWC_out | 5.52e-08 | 19 | 38 | 4 | SM00215 | |
| Domain | VWC | 1.02e-06 | 38 | 38 | 4 | SM00214 | |
| Domain | - | 1.14e-06 | 39 | 38 | 4 | 2.120.10.30 | |
| Domain | VWF_dom | 1.54e-06 | 42 | 38 | 4 | IPR001007 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.24e-06 | 46 | 38 | 4 | IPR011042 | |
| Domain | Ldl_recept_b | 2.78e-06 | 14 | 38 | 3 | PF00058 | |
| Domain | LDLRB | 2.78e-06 | 14 | 38 | 3 | PS51120 | |
| Domain | LY | 3.48e-06 | 15 | 38 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.48e-06 | 15 | 38 | 3 | IPR000033 | |
| Domain | Jagged/Serrate | 4.03e-06 | 2 | 38 | 2 | IPR026219 | |
| Domain | EMI | 5.18e-06 | 17 | 38 | 3 | PS51041 | |
| Domain | Thbs/COMP_coiled-coil | 1.21e-05 | 3 | 38 | 2 | IPR024665 | |
| Domain | COMP | 1.21e-05 | 3 | 38 | 2 | PF11598 | |
| Domain | FBN | 1.21e-05 | 3 | 38 | 2 | IPR011398 | |
| Domain | TSP3 | 4.02e-05 | 5 | 38 | 2 | PS51234 | |
| Domain | TSP_CTER | 4.02e-05 | 5 | 38 | 2 | PS51236 | |
| Domain | - | 4.02e-05 | 5 | 38 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 4.02e-05 | 5 | 38 | 2 | IPR008859 | |
| Domain | TSP_C | 4.02e-05 | 5 | 38 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 4.02e-05 | 5 | 38 | 2 | IPR017897 | |
| Domain | TSP_3 | 4.02e-05 | 5 | 38 | 2 | PF02412 | |
| Domain | Thrombospondin_3-like_rpt | 4.02e-05 | 5 | 38 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 4.02e-05 | 5 | 38 | 2 | IPR028974 | |
| Domain | Laminin_EGF | 4.86e-05 | 35 | 38 | 3 | PF00053 | |
| Domain | EGF_Lam | 4.86e-05 | 35 | 38 | 3 | SM00180 | |
| Domain | Laminin_EGF | 6.24e-05 | 38 | 38 | 3 | IPR002049 | |
| Domain | TB | 8.41e-05 | 7 | 38 | 2 | PF00683 | |
| Domain | - | 1.12e-04 | 8 | 38 | 2 | 3.90.290.10 | |
| Domain | TB | 1.44e-04 | 9 | 38 | 2 | PS51364 | |
| Domain | TB_dom | 1.44e-04 | 9 | 38 | 2 | IPR017878 | |
| Domain | TIL | 2.63e-04 | 12 | 38 | 2 | PF01826 | |
| Domain | C8 | 2.63e-04 | 12 | 38 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 3.10e-04 | 13 | 38 | 2 | IPR014853 | |
| Domain | C8 | 3.10e-04 | 13 | 38 | 2 | SM00832 | |
| Domain | PLAC | 3.61e-04 | 14 | 38 | 2 | PF08686 | |
| Domain | TIL_dom | 3.61e-04 | 14 | 38 | 2 | IPR002919 | |
| Domain | VWFD | 4.75e-04 | 16 | 38 | 2 | PS51233 | |
| Domain | VWD | 4.75e-04 | 16 | 38 | 2 | SM00216 | |
| Domain | EMI_domain | 4.75e-04 | 16 | 38 | 2 | IPR011489 | |
| Domain | VWF_type-D | 4.75e-04 | 16 | 38 | 2 | IPR001846 | |
| Domain | VWD | 4.75e-04 | 16 | 38 | 2 | PF00094 | |
| Domain | PLAC | 6.74e-04 | 19 | 38 | 2 | IPR010909 | |
| Domain | PLAC | 6.74e-04 | 19 | 38 | 2 | PS50900 | |
| Domain | Galactose-bd-like | 9.17e-04 | 94 | 38 | 3 | IPR008979 | |
| Domain | - | 9.45e-04 | 95 | 38 | 3 | 2.60.120.200 | |
| Domain | EGF_LAM_2 | 1.69e-03 | 30 | 38 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.69e-03 | 30 | 38 | 2 | PS01248 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 5.36e-13 | 7 | 29 | 5 | M27199 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.25e-11 | 27 | 29 | 6 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 3.26e-11 | 13 | 29 | 5 | M47423 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 7.58e-11 | 15 | 29 | 5 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.10e-10 | 16 | 29 | 5 | M47424 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.56e-10 | 17 | 29 | 5 | M39389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.81e-09 | 9 | 29 | 4 | M47866 | |
| Pathway | PID_NOTCH_PATHWAY | 1.82e-09 | 59 | 29 | 6 | M17 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 4.19e-09 | 31 | 29 | 5 | M592 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.41e-08 | 39 | 29 | 5 | MM14604 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.96e-08 | 45 | 29 | 5 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 3.31e-08 | 46 | 29 | 5 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.70e-08 | 47 | 29 | 5 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.59e-08 | 49 | 29 | 5 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.48e-08 | 19 | 29 | 4 | MM15594 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.03e-07 | 22 | 29 | 4 | M27210 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.09e-07 | 58 | 29 | 5 | M29616 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.41e-07 | 61 | 29 | 5 | M39540 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.77e-07 | 25 | 29 | 4 | M27879 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.74e-07 | 74 | 29 | 5 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 5.67e-07 | 33 | 29 | 4 | M604 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 6.26e-07 | 82 | 29 | 5 | MM15922 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.10e-07 | 37 | 29 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.85e-06 | 44 | 29 | 4 | M26969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.92e-06 | 300 | 29 | 7 | M610 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.82e-06 | 118 | 29 | 5 | M39852 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.74e-05 | 161 | 29 | 5 | M39770 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.73e-05 | 32 | 29 | 3 | MM14854 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 5.80e-05 | 37 | 29 | 3 | M39506 | |
| Pathway | WP_CANCER_PATHWAYS | 5.85e-05 | 507 | 29 | 7 | M48302 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 6.10e-05 | 6 | 29 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 6.10e-05 | 6 | 29 | 2 | M22074 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.81e-05 | 39 | 29 | 3 | MM14601 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 8.53e-05 | 7 | 29 | 2 | M47805 | |
| Pathway | PID_PS1_PATHWAY | 1.12e-04 | 46 | 29 | 3 | M70 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.31e-04 | 246 | 29 | 5 | M10189 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 1.46e-04 | 9 | 29 | 2 | M39869 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.64e-04 | 258 | 29 | 5 | MM14572 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 1.82e-04 | 10 | 29 | 2 | MM15839 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.82e-04 | 10 | 29 | 2 | MM14849 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 2.13e-04 | 57 | 29 | 3 | M48326 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.22e-04 | 11 | 29 | 2 | M27882 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 2.22e-04 | 11 | 29 | 2 | M39647 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.63e-04 | 154 | 29 | 4 | M39739 | |
| Pathway | BIOCARTA_HES_PATHWAY | 2.66e-04 | 12 | 29 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 2.66e-04 | 12 | 29 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.66e-04 | 12 | 29 | 2 | M47532 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 3.07e-04 | 464 | 29 | 6 | M27547 | |
| Pathway | REACTOME_NEPHRON_DEVELOPMENT | 3.14e-04 | 13 | 29 | 2 | M48245 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.59e-04 | 68 | 29 | 3 | M27303 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 3.66e-04 | 14 | 29 | 2 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 3.66e-04 | 14 | 29 | 2 | M16173 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.66e-04 | 14 | 29 | 2 | M27808 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.97e-04 | 76 | 29 | 3 | M27219 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 5.45e-04 | 17 | 29 | 2 | M39443 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.13e-04 | 18 | 29 | 2 | MM14775 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 6.21e-04 | 82 | 29 | 3 | M594 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 6.67e-04 | 84 | 29 | 3 | M7098 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 7.14e-04 | 86 | 29 | 3 | M2642 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.01e-03 | 97 | 29 | 3 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.14e-03 | 101 | 29 | 3 | M39448 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.19e-03 | 25 | 29 | 2 | M39713 | |
| Pathway | WP_1P36_COPY_NUMBER_VARIATION_SYNDROME | 1.53e-03 | 112 | 29 | 3 | M48072 | |
| Pathway | WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE | 2.60e-03 | 37 | 29 | 2 | M45513 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.74e-03 | 38 | 29 | 2 | MM14874 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.89e-03 | 39 | 29 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.89e-03 | 39 | 29 | 2 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.08e-03 | 143 | 29 | 3 | M27275 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 4.00e-03 | 46 | 29 | 2 | M48243 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 4.17e-03 | 47 | 29 | 2 | M646 | |
| Pathway | PID_TAP63_PATHWAY | 5.47e-03 | 54 | 29 | 2 | M256 | |
| Pathway | REACTOME_SOMITOGENESIS | 5.67e-03 | 55 | 29 | 2 | M48032 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 6.50e-03 | 59 | 29 | 2 | M39886 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 6.50e-03 | 59 | 29 | 2 | M46460 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 7.16e-03 | 62 | 29 | 2 | MM14686 | |
| Pathway | WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT | 7.16e-03 | 62 | 29 | 2 | M45532 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 7.31e-03 | 381 | 29 | 4 | M48063 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 7.38e-03 | 63 | 29 | 2 | M27862 | |
| Pathway | WP_FOCAL_ADHESION | 7.73e-03 | 199 | 29 | 3 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.73e-03 | 199 | 29 | 3 | M7253 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 8.08e-03 | 66 | 29 | 2 | M18 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 8.80e-03 | 69 | 29 | 2 | M46439 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 9.55e-03 | 72 | 29 | 2 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 9.81e-03 | 73 | 29 | 2 | MM15906 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 1.01e-02 | 74 | 29 | 2 | M39857 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 1.03e-02 | 75 | 29 | 2 | M27032 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.06e-02 | 76 | 29 | 2 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.09e-02 | 77 | 29 | 2 | MM14670 | |
| Pubmed | 1.49e-13 | 9 | 38 | 5 | 16245338 | ||
| Pubmed | 1.49e-13 | 9 | 38 | 5 | 12122015 | ||
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 1.49e-13 | 9 | 38 | 5 | 10837027 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.97e-13 | 10 | 38 | 5 | 23665443 | |
| Pubmed | 9.33e-13 | 12 | 38 | 5 | 15465494 | ||
| Pubmed | Notch ligands transduce different magnitudes of signaling critical for determination of T-cell fate. | 1.21e-12 | 4 | 38 | 4 | 20602435 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 9315665 | ||
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 1.21e-12 | 4 | 38 | 4 | 23300864 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 9858728 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.51e-12 | 13 | 38 | 5 | 11578869 | |
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 14757642 | ||
| Pubmed | 3.53e-12 | 15 | 38 | 5 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 5.13e-12 | 16 | 38 | 5 | 12617809 | |
| Pubmed | 5.13e-12 | 16 | 38 | 5 | 17273555 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 6.05e-12 | 5 | 38 | 4 | 11006133 | |
| Pubmed | 6.05e-12 | 5 | 38 | 4 | 12175503 | ||
| Pubmed | 7.26e-12 | 17 | 38 | 5 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 7.26e-12 | 17 | 38 | 5 | 15821257 | |
| Pubmed | 1.00e-11 | 18 | 38 | 5 | 18093989 | ||
| Pubmed | 1.00e-11 | 18 | 38 | 5 | 15689374 | ||
| Pubmed | 1.36e-11 | 19 | 38 | 5 | 18505817 | ||
| Pubmed | 1.36e-11 | 19 | 38 | 5 | 16518823 | ||
| Pubmed | 1.81e-11 | 6 | 38 | 4 | 10958687 | ||
| Pubmed | Jagged and Delta-like ligands control distinct events during airway progenitor cell differentiation. | 2.38e-11 | 21 | 38 | 5 | 31631837 | |
| Pubmed | 2.38e-11 | 21 | 38 | 5 | 19686682 | ||
| Pubmed | 2.38e-11 | 21 | 38 | 5 | 28656980 | ||
| Pubmed | 3.08e-11 | 22 | 38 | 5 | 21750033 | ||
| Pubmed | 3.93e-11 | 23 | 38 | 5 | 14701881 | ||
| Pubmed | 4.23e-11 | 7 | 38 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 4.23e-11 | 7 | 38 | 4 | 12846471 | |
| Pubmed | Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. | 4.23e-11 | 7 | 38 | 4 | 21238454 | |
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 7.66e-11 | 26 | 38 | 5 | 19369401 | |
| Pubmed | Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. | 8.45e-11 | 8 | 38 | 4 | 24647000 | |
| Pubmed | 8.45e-11 | 8 | 38 | 4 | 9858718 | ||
| Pubmed | 8.45e-11 | 8 | 38 | 4 | 11044610 | ||
| Pubmed | 1.38e-10 | 29 | 38 | 5 | 25535917 | ||
| Pubmed | 1.52e-10 | 9 | 38 | 4 | 11118901 | ||
| Pubmed | Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. | 1.52e-10 | 9 | 38 | 4 | 28714968 | |
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 1.52e-10 | 9 | 38 | 4 | 11944948 | |
| Pubmed | Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. | 1.52e-10 | 9 | 38 | 4 | 17685488 | |
| Pubmed | Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation. | 1.52e-10 | 9 | 38 | 4 | 20727173 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 1.65e-10 | 30 | 38 | 5 | 24552588 | |
| Pubmed | 2.53e-10 | 10 | 38 | 4 | 24015274 | ||
| Pubmed | Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. | 2.75e-10 | 33 | 38 | 5 | 16000382 | |
| Pubmed | 3.22e-10 | 34 | 38 | 5 | 21311046 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 3.75e-10 | 35 | 38 | 5 | 21252157 | |
| Pubmed | The Retinal Pigment Epithelium Is a Notch Signaling Niche in the Mouse Retina. | 3.75e-10 | 35 | 38 | 5 | 28402857 | |
| Pubmed | 3.97e-10 | 11 | 38 | 4 | 10878608 | ||
| Pubmed | 3.97e-10 | 11 | 38 | 4 | 12866128 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 4.96e-10 | 86 | 38 | 6 | 28327460 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 8.60e-10 | 13 | 38 | 4 | 31202705 | |
| Pubmed | Notch signaling is required for the maintenance of enteric neural crest progenitors. | 8.60e-10 | 13 | 38 | 4 | 18832397 | |
| Pubmed | 8.60e-10 | 13 | 38 | 4 | 34838591 | ||
| Pubmed | 8.62e-10 | 41 | 38 | 5 | 22675208 | ||
| Pubmed | 1.20e-09 | 14 | 38 | 4 | 18528438 | ||
| Pubmed | Notch1 is required for neuronal and glial differentiation in the cerebellum. | 1.20e-09 | 14 | 38 | 4 | 11807030 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 12684674 | ||
| Pubmed | Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. | 1.20e-09 | 3 | 38 | 3 | 20812035 | |
| Pubmed | Both Notch1 and its ligands in B cells promote antibody production. | 1.20e-09 | 3 | 38 | 3 | 28863329 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 22080880 | ||
| Pubmed | Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. | 1.20e-09 | 3 | 38 | 3 | 9716576 | |
| Pubmed | Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions. | 1.20e-09 | 3 | 38 | 3 | 21372153 | |
| Pubmed | Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1. | 1.20e-09 | 3 | 38 | 3 | 23839946 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 20154142 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 26062426 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 15781650 | ||
| Pubmed | 1.24e-09 | 100 | 38 | 6 | 24859004 | ||
| Pubmed | The notch pathway positively regulates programmed cell death during erythroid differentiation. | 1.25e-09 | 44 | 38 | 5 | 17476283 | |
| Pubmed | BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. | 1.64e-09 | 15 | 38 | 4 | 16324690 | |
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 1.64e-09 | 15 | 38 | 4 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 1.64e-09 | 15 | 38 | 4 | 16914494 | |
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 1.76e-09 | 47 | 38 | 5 | 32747435 | |
| Pubmed | 1.96e-09 | 48 | 38 | 5 | 35247391 | ||
| Pubmed | Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. | 2.18e-09 | 16 | 38 | 4 | 17229764 | |
| Pubmed | 2.18e-09 | 16 | 38 | 4 | 10842072 | ||
| Pubmed | 2.18e-09 | 16 | 38 | 4 | 22464328 | ||
| Pubmed | 2.18e-09 | 16 | 38 | 4 | 32161758 | ||
| Pubmed | 2.42e-09 | 50 | 38 | 5 | 27510977 | ||
| Pubmed | 3.39e-09 | 118 | 38 | 6 | 21078624 | ||
| Pubmed | 4.64e-09 | 19 | 38 | 4 | 20335360 | ||
| Pubmed | 4.64e-09 | 19 | 38 | 4 | 25691540 | ||
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 18824585 | ||
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 10837254 | ||
| Pubmed | Notch signalling pathway mediates hair cell development in mammalian cochlea. | 4.81e-09 | 4 | 38 | 3 | 10080181 | |
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 4.81e-09 | 4 | 38 | 3 | 22390640 | |
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 4.81e-09 | 4 | 38 | 3 | 32820046 | |
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 20819128 | ||
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 36376768 | ||
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 22020917 | ||
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 23162128 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 4.81e-09 | 4 | 38 | 3 | 20040020 | |
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 24398584 | ||
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 5.79e-09 | 20 | 38 | 4 | 29961574 | |
| Pubmed | Mesenchymal cells are required for functional development of thymic epithelial cells. | 7.15e-09 | 21 | 38 | 4 | 17625108 | |
| Pubmed | 7.15e-09 | 21 | 38 | 4 | 14651921 | ||
| Pubmed | Sequential Notch activation regulates ventricular chamber development. | 8.73e-09 | 22 | 38 | 4 | 26641715 | |
| Pubmed | Notch signalling regulates epibranchial placode patterning and segregation. | 1.06e-08 | 23 | 38 | 4 | 31988190 | |
| Pubmed | Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis. | 1.06e-08 | 23 | 38 | 4 | 19897741 | |
| Pubmed | 1.06e-08 | 23 | 38 | 4 | 19191219 | ||
| Pubmed | 1.06e-08 | 23 | 38 | 4 | 24337118 | ||
| Interaction | NTN5 interactions | 1.30e-14 | 24 | 37 | 7 | int:NTN5 | |
| Interaction | MFAP5 interactions | 4.08e-14 | 52 | 37 | 8 | int:MFAP5 | |
| Interaction | IGFL3 interactions | 8.87e-13 | 75 | 37 | 8 | int:IGFL3 | |
| Interaction | ZFP41 interactions | 8.48e-10 | 57 | 37 | 6 | int:ZFP41 | |
| Interaction | NOTCH3 interactions | 1.29e-09 | 113 | 37 | 7 | int:NOTCH3 | |
| Interaction | MFAP2 interactions | 4.71e-09 | 12 | 37 | 4 | int:MFAP2 | |
| Interaction | ZNF408 interactions | 2.42e-07 | 145 | 37 | 6 | int:ZNF408 | |
| Interaction | TAFA3 interactions | 3.02e-07 | 78 | 37 | 5 | int:TAFA3 | |
| Interaction | DLK2 interactions | 5.43e-07 | 36 | 37 | 4 | int:DLK2 | |
| Interaction | FBXO2 interactions | 6.43e-07 | 411 | 37 | 8 | int:FBXO2 | |
| Interaction | WNT3A interactions | 1.92e-06 | 49 | 37 | 4 | int:WNT3A | |
| Interaction | FOXD4L6 interactions | 1.92e-06 | 49 | 37 | 4 | int:FOXD4L6 | |
| Interaction | ST14 interactions | 1.95e-06 | 207 | 37 | 6 | int:ST14 | |
| Interaction | IGSF5 interactions | 2.04e-06 | 14 | 37 | 3 | int:IGSF5 | |
| Interaction | CACNA1A interactions | 2.91e-06 | 123 | 37 | 5 | int:CACNA1A | |
| Interaction | DEFB123 interactions | 3.14e-06 | 16 | 37 | 3 | int:DEFB123 | |
| Interaction | NEURL1 interactions | 3.81e-06 | 17 | 37 | 3 | int:NEURL1 | |
| Interaction | PLAT interactions | 5.30e-06 | 63 | 37 | 4 | int:PLAT | |
| Interaction | ZNF224 interactions | 6.36e-06 | 20 | 37 | 3 | int:ZNF224 | |
| Interaction | NOTCH2 interactions | 1.02e-05 | 423 | 37 | 7 | int:NOTCH2 | |
| Interaction | PRG2 interactions | 1.22e-05 | 285 | 37 | 6 | int:PRG2 | |
| Interaction | MFNG interactions | 1.62e-05 | 27 | 37 | 3 | int:MFNG | |
| Interaction | ELN interactions | 2.01e-05 | 29 | 37 | 3 | int:ELN | |
| Interaction | ELSPBP1 interactions | 2.39e-05 | 92 | 37 | 4 | int:ELSPBP1 | |
| Interaction | ZNF74 interactions | 3.28e-05 | 34 | 37 | 3 | int:ZNF74 | |
| Interaction | NOTCH1 interactions | 3.58e-05 | 345 | 37 | 6 | int:NOTCH1 | |
| Interaction | EDN3 interactions | 4.50e-05 | 108 | 37 | 4 | int:EDN3 | |
| Interaction | UST interactions | 4.60e-05 | 38 | 37 | 3 | int:UST | |
| Interaction | CCN3 interactions | 4.60e-05 | 38 | 37 | 3 | int:CCN3 | |
| Interaction | ATXN7 interactions | 4.66e-05 | 109 | 37 | 4 | int:ATXN7 | |
| Interaction | JAG2 interactions | 4.83e-05 | 110 | 37 | 4 | int:JAG2 | |
| Interaction | DLL4 interactions | 4.90e-05 | 6 | 37 | 2 | int:DLL4 | |
| Interaction | JAG1 interactions | 5.79e-05 | 41 | 37 | 3 | int:JAG1 | |
| Interaction | LYZL1 interactions | 6.35e-05 | 118 | 37 | 4 | int:LYZL1 | |
| Interaction | POFUT1 interactions | 6.68e-05 | 43 | 37 | 3 | int:POFUT1 | |
| Interaction | DEFB136 interactions | 7.16e-05 | 44 | 37 | 3 | int:DEFB136 | |
| Interaction | ZDHHC15 interactions | 7.95e-05 | 125 | 37 | 4 | int:ZDHHC15 | |
| Interaction | WNT7A interactions | 9.31e-05 | 48 | 37 | 3 | int:WNT7A | |
| Interaction | SFRP4 interactions | 9.90e-05 | 49 | 37 | 3 | int:SFRP4 | |
| Interaction | GFI1B interactions | 1.10e-04 | 136 | 37 | 4 | int:GFI1B | |
| Interaction | FBN1 interactions | 1.12e-04 | 51 | 37 | 3 | int:FBN1 | |
| Interaction | TYW3 interactions | 1.25e-04 | 53 | 37 | 3 | int:TYW3 | |
| Interaction | VCAN interactions | 1.32e-04 | 54 | 37 | 3 | int:VCAN | |
| Interaction | ADAM30 interactions | 1.48e-04 | 56 | 37 | 3 | int:ADAM30 | |
| Interaction | KLK15 interactions | 1.65e-04 | 151 | 37 | 4 | int:KLK15 | |
| Interaction | HRG interactions | 2.10e-04 | 63 | 37 | 3 | int:HRG | |
| Interaction | ZNF563 interactions | 2.14e-04 | 12 | 37 | 2 | int:ZNF563 | |
| Interaction | FBN2 interactions | 2.30e-04 | 65 | 37 | 3 | int:FBN2 | |
| Interaction | FBLN2 interactions | 2.41e-04 | 66 | 37 | 3 | int:FBLN2 | |
| Interaction | SVEP1 interactions | 2.53e-04 | 13 | 37 | 2 | int:SVEP1 | |
| Interaction | P2RX2 interactions | 2.87e-04 | 70 | 37 | 3 | int:P2RX2 | |
| Interaction | RNASE4 interactions | 2.94e-04 | 14 | 37 | 2 | int:RNASE4 | |
| Interaction | LRPAP1 interactions | 3.23e-04 | 180 | 37 | 4 | int:LRPAP1 | |
| Interaction | LGALS1 interactions | 3.33e-04 | 332 | 37 | 5 | int:LGALS1 | |
| Interaction | ATN1 interactions | 3.73e-04 | 187 | 37 | 4 | int:ATN1 | |
| Interaction | MBD1 interactions | 3.79e-04 | 77 | 37 | 3 | int:MBD1 | |
| Interaction | ZNF707 interactions | 4.09e-04 | 79 | 37 | 3 | int:ZNF707 | |
| Interaction | HOXA1 interactions | 4.58e-04 | 356 | 37 | 5 | int:HOXA1 | |
| Interaction | SERPINA10 interactions | 4.93e-04 | 18 | 37 | 2 | int:SERPINA10 | |
| Interaction | DNAJB9 interactions | 4.99e-04 | 202 | 37 | 4 | int:DNAJB9 | |
| Interaction | SIRPD interactions | 5.25e-04 | 86 | 37 | 3 | int:SIRPD | |
| Interaction | CCN6 interactions | 5.50e-04 | 19 | 37 | 2 | int:CCN6 | |
| Interaction | TIMP3 interactions | 6.00e-04 | 90 | 37 | 3 | int:TIMP3 | |
| Interaction | DEFB125 interactions | 6.10e-04 | 20 | 37 | 2 | int:DEFB125 | |
| Interaction | TMEM106A interactions | 6.20e-04 | 214 | 37 | 4 | int:TMEM106A | |
| Interaction | LY86 interactions | 6.54e-04 | 217 | 37 | 4 | int:LY86 | |
| Interaction | EGFL6 interactions | 6.74e-04 | 21 | 37 | 2 | int:EGFL6 | |
| Interaction | HSPG2 interactions | 7.68e-04 | 98 | 37 | 3 | int:HSPG2 | |
| Interaction | GOLGA8G interactions | 8.82e-04 | 24 | 37 | 2 | int:GOLGA8G | |
| Interaction | TAB1 interactions | 1.14e-03 | 252 | 37 | 4 | int:TAB1 | |
| Interaction | FEZF1 interactions | 1.20e-03 | 28 | 37 | 2 | int:FEZF1 | |
| Interaction | ZNF517 interactions | 1.29e-03 | 29 | 37 | 2 | int:ZNF517 | |
| Interaction | ALG12 interactions | 1.47e-03 | 31 | 37 | 2 | int:ALG12 | |
| Interaction | LYPD4 interactions | 1.48e-03 | 123 | 37 | 3 | int:LYPD4 | |
| Interaction | CFC1 interactions | 1.59e-03 | 126 | 37 | 3 | int:CFC1 | |
| Interaction | THBS1 interactions | 1.62e-03 | 127 | 37 | 3 | int:THBS1 | |
| Interaction | MSTN interactions | 1.67e-03 | 33 | 37 | 2 | int:MSTN | |
| Interaction | FSTL4 interactions | 1.77e-03 | 34 | 37 | 2 | int:FSTL4 | |
| Interaction | ECEL1 interactions | 1.89e-03 | 134 | 37 | 3 | int:ECEL1 | |
| GeneFamily | Low density lipoprotein receptors | 4.44e-07 | 13 | 22 | 3 | 634 | |
| GeneFamily | Ubiquitin specific peptidases | 2.09e-03 | 56 | 22 | 2 | 366 | |
| Coexpression | NABA_MATRISOME | FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 ADAMTSL3 SSPOP IL23A EMILIN1 F10 ST14 PCSK6 FGL2 LAMA1 | 2.28e-12 | 1008 | 37 | 15 | MM17056 |
| Coexpression | NABA_MATRISOME | FBLN1 THBS3 FBN1 FBN2 COMP MEGF6 ADAMTSL3 SSPOP IL23A EMILIN1 F10 ST14 PCSK6 FGL2 LAMA1 | 2.93e-12 | 1026 | 37 | 15 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.00e-12 | 191 | 37 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.31e-12 | 196 | 37 | 9 | M3008 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.83e-11 | 16 | 37 | 5 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.83e-11 | 16 | 37 | 5 | M2207 | |
| Coexpression | NABA_CORE_MATRISOME | 1.11e-10 | 270 | 37 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.30e-10 | 275 | 37 | 9 | M5884 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 3.62e-07 | 42 | 37 | 4 | M5895 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 7.39e-07 | 50 | 37 | 4 | MM403 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.38e-06 | 137 | 37 | 5 | M40313 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 3.25e-06 | 163 | 37 | 5 | M12112 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 5.83e-06 | 25 | 37 | 3 | M9946 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 8.79e-06 | 200 | 37 | 5 | M5930 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 9.43e-06 | 767 | 37 | 8 | M39209 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 1.25e-05 | 32 | 37 | 3 | M5903 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.53e-05 | 385 | 37 | 6 | M39264 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.84e-05 | 233 | 37 | 5 | M13273 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN | 2.88e-05 | 125 | 37 | 4 | M19629 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.19e-05 | 479 | 37 | 6 | M2573 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 5.40e-05 | 8 | 37 | 2 | M9884 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.43e-05 | 483 | 37 | 6 | MM1082 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 5.72e-05 | 149 | 37 | 4 | M45703 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_DN | 7.73e-05 | 161 | 37 | 4 | M15047 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 7.97e-05 | 59 | 37 | 3 | M47993 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 1.27e-04 | 12 | 37 | 2 | M17374 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 1.35e-04 | 355 | 37 | 5 | M45758 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN | 1.75e-04 | 199 | 37 | 4 | M9599 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 1.75e-04 | 199 | 37 | 4 | M5406 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP | 1.78e-04 | 200 | 37 | 4 | M5273 | |
| Coexpression | HALLMARK_P53_PATHWAY | 1.78e-04 | 200 | 37 | 4 | M5939 | |
| Coexpression | GSE17721_0.5H_VS_4H_CPG_BMDC_DN | 1.78e-04 | 200 | 37 | 4 | M4125 | |
| Coexpression | WONG_ENDMETRIUM_CANCER_DN | 1.83e-04 | 78 | 37 | 3 | M1311 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 1.90e-04 | 382 | 37 | 5 | M45756 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 1.97e-04 | 80 | 37 | 3 | M15368 | |
| Coexpression | WARTERS_RESPONSE_TO_IR_SKIN | 2.20e-04 | 83 | 37 | 3 | M2600 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 2.60e-04 | 17 | 37 | 2 | M47995 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | 3.18e-04 | 427 | 37 | 5 | M17923 | |
| Coexpression | NABA_ECM_REGULATORS | 3.46e-04 | 238 | 37 | 4 | M3468 | |
| Coexpression | KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3 | 3.48e-04 | 97 | 37 | 3 | M16734 | |
| Coexpression | NABA_ECM_REGULATORS | 3.68e-04 | 242 | 37 | 4 | MM17062 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 4.56e-04 | 256 | 37 | 4 | M10952 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 4.65e-04 | 107 | 37 | 3 | M4913 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 4.90e-04 | 261 | 37 | 4 | M1834 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 5.39e-04 | 738 | 37 | 6 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 5.91e-04 | 751 | 37 | 6 | M5885 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 6.03e-04 | 117 | 37 | 3 | M39300 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 6.66e-04 | 27 | 37 | 2 | M40935 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 6.66e-04 | 27 | 37 | 2 | M47994 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 7.18e-04 | 289 | 37 | 4 | M41750 | |
| Coexpression | WANG_MLL_TARGETS | 7.65e-04 | 294 | 37 | 4 | M2456 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 8.23e-04 | 30 | 37 | 2 | M47990 | |
| Coexpression | GSE12505_WT_VS_E2_2_HET_PDC_UP | 8.37e-04 | 131 | 37 | 3 | M437 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.55e-08 | 165 | 38 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 8.12e-07 | 783 | 38 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.73e-06 | 480 | 38 | 8 | ratio_MESO_vs_SC_1000_K5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 4.51e-06 | 62 | 38 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_100 | 5.02e-06 | 19 | 38 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_100_k5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 5.46e-06 | 65 | 38 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 5.89e-06 | 398 | 38 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 6.41e-06 | 148 | 38 | 5 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_500 | 9.17e-06 | 74 | 38 | 4 | gudmap_developingKidney_e15.5_S-shaped body_500_k1 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.45e-05 | 175 | 38 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_200 | 2.53e-05 | 32 | 38 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_500 | 3.66e-05 | 105 | 38 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_500_k5 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | 4.52e-05 | 982 | 38 | 9 | PCBC_ratio_MESO-5_vs_SC_1000 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | 8.28e-05 | 411 | 38 | 6 | gudmap_developingKidney_e12.5_renal vesicle_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.43e-05 | 130 | 38 | 4 | gudmap_developingKidney_e15.5_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.08e-04 | 267 | 38 | 5 | gudmap_developingKidney_e12.5_renal vesicle_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.32e-04 | 146 | 38 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 1.39e-04 | 148 | 38 | 4 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 2.16e-04 | 166 | 38 | 4 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.17e-04 | 310 | 38 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.78e-04 | 327 | 38 | 5 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.19e-04 | 337 | 38 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.67e-04 | 78 | 38 | 3 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_100 | 3.67e-04 | 78 | 38 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 3.73e-04 | 768 | 38 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 3.88e-04 | 773 | 38 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.00e-04 | 354 | 38 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 4.00e-04 | 777 | 38 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 4.89e-04 | 370 | 38 | 5 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 4.99e-04 | 207 | 38 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_1000 | 5.25e-04 | 813 | 38 | 7 | gudmap_developingKidney_e12.5_renal vesicle_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_100 | 5.40e-04 | 89 | 38 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.46e-04 | 212 | 38 | 4 | gudmap_developingKidney_e15.5_S-shaped body_1000_k1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.94e-04 | 1094 | 38 | 8 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 6.17e-04 | 219 | 38 | 4 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 6.66e-04 | 846 | 38 | 7 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.75e-04 | 848 | 38 | 7 | ratio_ECTO_vs_SC_2500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_500 | 7.44e-04 | 406 | 38 | 5 | gudmap_developingKidney_e15.5_S-shaped body_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.03e-03 | 658 | 38 | 6 | ratio_MESO_vs_SC_2500_K3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.03e-03 | 437 | 38 | 5 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.06e-03 | 439 | 38 | 5 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.18e-03 | 450 | 38 | 5 | GSM777063_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.25e-03 | 265 | 38 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.29e-03 | 459 | 38 | 5 | GSM777037_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.35e-03 | 122 | 38 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.53e-03 | 280 | 38 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 1.62e-03 | 284 | 38 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.72e-10 | 181 | 38 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-10 | 198 | 38 | 7 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-10 | 198 | 38 | 7 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-08 | 186 | 38 | 6 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-08 | 188 | 38 | 6 | 2cfa41c64eccb28b5e22f0f91bbc921b75713245 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.60e-08 | 197 | 38 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.60e-08 | 197 | 38 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-08 | 198 | 38 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.70e-08 | 199 | 38 | 6 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-07 | 152 | 38 | 5 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-07 | 165 | 38 | 5 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-07 | 165 | 38 | 5 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-07 | 165 | 38 | 5 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-07 | 165 | 38 | 5 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.80e-07 | 175 | 38 | 5 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.80e-07 | 175 | 38 | 5 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-07 | 176 | 38 | 5 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-07 | 176 | 38 | 5 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.14e-07 | 178 | 38 | 5 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.25e-07 | 179 | 38 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-07 | 183 | 38 | 5 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-07 | 183 | 38 | 5 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-07 | 183 | 38 | 5 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-07 | 183 | 38 | 5 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.74e-07 | 183 | 38 | 5 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.74e-07 | 183 | 38 | 5 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-07 | 184 | 38 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-07 | 184 | 38 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-07 | 184 | 38 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.01e-07 | 185 | 38 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-07 | 187 | 38 | 5 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.42e-07 | 188 | 38 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-07 | 188 | 38 | 5 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 5.42e-07 | 188 | 38 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-07 | 188 | 38 | 5 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-07 | 189 | 38 | 5 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-07 | 189 | 38 | 5 | 56f43e00d81cf3cdf0c39f8d7120f5beab72e258 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-07 | 189 | 38 | 5 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.71e-07 | 190 | 38 | 5 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.86e-07 | 191 | 38 | 5 | b680e0c35f1004be36f9f0680ae3c62952e2b607 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.86e-07 | 191 | 38 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.86e-07 | 191 | 38 | 5 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 191 | 38 | 5 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 191 | 38 | 5 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.01e-07 | 192 | 38 | 5 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.01e-07 | 192 | 38 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-07 | 193 | 38 | 5 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.17e-07 | 193 | 38 | 5 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-07 | 193 | 38 | 5 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-07 | 194 | 38 | 5 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-07 | 194 | 38 | 5 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-07 | 194 | 38 | 5 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.49e-07 | 195 | 38 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-07 | 195 | 38 | 5 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.49e-07 | 195 | 38 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.49e-07 | 195 | 38 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|World / Lineage and Cell class | 6.49e-07 | 195 | 38 | 5 | d53974d1866e23c894ffd492ea11d20422919b11 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-07 | 195 | 38 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-07 | 195 | 38 | 5 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-07 | 196 | 38 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-07 | 196 | 38 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.66e-07 | 196 | 38 | 5 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.66e-07 | 196 | 38 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.83e-07 | 197 | 38 | 5 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.00e-07 | 198 | 38 | 5 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.00e-07 | 198 | 38 | 5 | 4961a3e9b953679648586afed04869ff36b81820 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-07 | 198 | 38 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-07 | 199 | 38 | 5 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-07 | 199 | 38 | 5 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.18e-07 | 199 | 38 | 5 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-07 | 199 | 38 | 5 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.18e-07 | 199 | 38 | 5 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-07 | 199 | 38 | 5 | 136f24597ddca5cf2175120975c94782a3232ec6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-07 | 199 | 38 | 5 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.18e-07 | 199 | 38 | 5 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.36e-07 | 200 | 38 | 5 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.36e-07 | 200 | 38 | 5 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.36e-07 | 200 | 38 | 5 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.36e-07 | 200 | 38 | 5 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.36e-07 | 200 | 38 | 5 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 7.36e-07 | 200 | 38 | 5 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.36e-07 | 200 | 38 | 5 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 7.36e-07 | 200 | 38 | 5 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 7.36e-07 | 200 | 38 | 5 | ee3d06865a6300e1279edf6664320b71647f5efb | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.36e-07 | 200 | 38 | 5 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 6.28e-06 | 141 | 38 | 4 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.81e-06 | 149 | 38 | 4 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | Dendritic_Cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 8.90e-06 | 154 | 38 | 4 | 65013f696da623d37f1e3447a294dfb3c31ae93b | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 9.85e-06 | 158 | 38 | 4 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.01e-05 | 159 | 38 | 4 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.01e-05 | 159 | 38 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-05 | 161 | 38 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-05 | 161 | 38 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-05 | 161 | 38 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 162 | 38 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| Computational | Metal / Ca ion binding. | 4.68e-07 | 133 | 25 | 6 | MODULE_324 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Drug | AC1L1GUQ | 1.98e-08 | 50 | 38 | 5 | CID000003849 | |
| Drug | AC1L1C6C | 1.78e-07 | 77 | 38 | 5 | CID000001759 | |
| Drug | lead stearate | 2.76e-07 | 84 | 38 | 5 | CID000061258 | |
| Drug | Rgd Peptide | 2.62e-06 | 239 | 38 | 6 | CID000104802 | |
| Drug | pifarnine | 3.44e-06 | 18 | 38 | 3 | CID006436032 | |
| Drug | benzamidine | 4.43e-06 | 147 | 38 | 5 | CID000002332 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.10e-05 | 83 | 38 | 4 | CID011968896 | |
| Drug | monatepil | 1.52e-05 | 29 | 38 | 3 | CID000060810 | |
| Drug | AC1L1EPA | 1.62e-05 | 4 | 38 | 2 | CID000028140 | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 1.75e-05 | 195 | 38 | 5 | 5564_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 3909_UP | |
| Drug | S-2238 | 2.95e-05 | 36 | 38 | 3 | CID000123853 | |
| Drug | beta-hydroxyasparagine | 3.76e-05 | 39 | 38 | 3 | CID000152191 | |
| Drug | Leucomyosuppressin | 4.05e-05 | 6 | 38 | 2 | CID000176039 | |
| Drug | Tnrnflrfamide | 4.05e-05 | 6 | 38 | 2 | CID003081636 | |
| Drug | silver-sulfide (Ag2S | 5.67e-05 | 7 | 38 | 2 | CID000030686 | |
| Drug | S-2648 | 6.61e-05 | 47 | 38 | 3 | CID000123687 | |
| Drug | tripterine | 8.36e-05 | 139 | 38 | 4 | ctd:C050414 | |
| Drug | Leupeptin hydrochloride | 9.13e-05 | 276 | 38 | 5 | CID000003910 | |
| Drug | zoledronic acid | 1.10e-04 | 1472 | 38 | 10 | ctd:C088658 | |
| Drug | poly(GEMA | 1.21e-04 | 10 | 38 | 2 | CID003083177 | |
| Drug | 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine | 1.21e-04 | 10 | 38 | 2 | ctd:C028145 | |
| Drug | 5a-formylbicyclomycin | 1.24e-04 | 58 | 38 | 3 | CID005288192 | |
| Drug | fullerene C60 | 1.27e-04 | 1498 | 38 | 10 | ctd:C069837 | |
| Drug | AC1L9KDM | 1.37e-04 | 60 | 38 | 3 | CID000447021 | |
| Drug | 25-hydroxycholesterol | 1.44e-04 | 160 | 38 | 4 | CID000065094 | |
| Drug | benzimidazole-2 | 1.48e-04 | 11 | 38 | 2 | CID005329338 | |
| Drug | Biggam | 1.48e-04 | 11 | 38 | 2 | CID000196426 | |
| Drug | probucol | 1.51e-04 | 162 | 38 | 4 | CID000004912 | |
| Drug | A25152 | 1.52e-04 | 62 | 38 | 3 | CID000002956 | |
| Drug | Arginylarginine | 1.55e-04 | 163 | 38 | 4 | CID000151956 | |
| Drug | BAEE | 1.67e-04 | 64 | 38 | 3 | CID000123880 | |
| Drug | Rgh 2958 | 1.77e-04 | 12 | 38 | 2 | CID000124710 | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 1.82e-04 | 170 | 38 | 4 | 978_UP | |
| Drug | diisopropylfluorophosphate | 1.85e-04 | 321 | 38 | 5 | CID000005936 | |
| Drug | prulifloxacin | 2.17e-04 | 70 | 38 | 3 | CID000065947 | |
| Drug | triterpene | 2.17e-04 | 70 | 38 | 3 | CID000122724 | |
| Drug | MRK 003 | 2.30e-04 | 760 | 38 | 7 | ctd:C523799 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.31e-04 | 181 | 38 | 4 | 5578_UP | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.36e-04 | 182 | 38 | 4 | 2049_UP | |
| Drug | azar | 2.67e-04 | 75 | 38 | 3 | CID000015967 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.72e-04 | 189 | 38 | 4 | 4450_UP | |
| Drug | peptidomimetic inhibitor | 2.78e-04 | 190 | 38 | 4 | CID005288092 | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 2.78e-04 | 190 | 38 | 4 | 4493_DN | |
| Drug | S 2441 | 2.81e-04 | 15 | 38 | 2 | CID000133194 | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A | 2.89e-04 | 192 | 38 | 4 | 2799_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 3811_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 3845_UP | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A | 2.95e-04 | 193 | 38 | 4 | 1715_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HG-U133A | 2.95e-04 | 193 | 38 | 4 | 1896_UP | |
| Drug | tetrathiomolybdate | 2.99e-04 | 78 | 38 | 3 | ctd:C020809 | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4417_DN | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 2780_UP | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4401_UP | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 6903_UP | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 2770_UP | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 2156_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2270_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HG-U133A | 3.13e-04 | 196 | 38 | 4 | 492_DN | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2923_DN | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 6027_UP | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3070_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2198_DN | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2280_UP | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3385_UP | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6211_UP | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2888_UP | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2873_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6449_UP | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3401_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6803_UP | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3813_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4797_UP | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6383_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2002_DN | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6495_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6517_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 4132_UP | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2980_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2521_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2489_DN | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6384_UP | |
| Drug | Pipemidic acid [51940-44-4]; Up 200; 13.2uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3093_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 6456_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 2747_UP | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 7133_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 3.31e-04 | 199 | 38 | 4 | 408_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A | 3.38e-04 | 200 | 38 | 4 | 2348_UP | |
| Drug | indomethacin, USP; Up 200; 100uM; MCF7; HG-U133A | 3.38e-04 | 200 | 38 | 4 | 453_UP | |
| Drug | gedunin | 3.72e-04 | 84 | 38 | 3 | ctd:C106014 | |
| Drug | AC1L4UUJ | 4.08e-04 | 18 | 38 | 2 | CID000164475 | |
| Drug | MMI270 | 4.08e-04 | 18 | 38 | 2 | CID000446504 | |
| Drug | perchlorate | 4.56e-04 | 90 | 38 | 3 | CID000024247 | |
| Drug | S 2160 | 5.06e-04 | 20 | 38 | 2 | CID000189147 | |
| Drug | FA 5 | 5.06e-04 | 20 | 38 | 2 | CID000193730 | |
| Drug | iodine monochloride | 5.58e-04 | 21 | 38 | 2 | CID000024640 | |
| Drug | TAAD | 5.58e-04 | 21 | 38 | 2 | CID000133445 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.57e-09 | 53 | 36 | 5 | C4707243 | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 1.45e-06 | 2 | 36 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 1.45e-06 | 2 | 36 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.76e-06 | 80 | 36 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Carcinoma, Pancreatic Ductal | 3.32e-06 | 24 | 36 | 3 | C0887833 | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.34e-06 | 3 | 36 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | cortical thickness | 5.62e-06 | 1113 | 36 | 9 | EFO_0004840 | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 8.67e-06 | 4 | 36 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 8.67e-06 | 4 | 36 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Adams Oliver syndrome | 2.16e-05 | 6 | 36 | 2 | C0265268 | |
| Disease | Adams-Oliver syndrome 1 | 2.16e-05 | 6 | 36 | 2 | C4551482 | |
| Disease | Congenital defect of skull and scalp | 2.16e-05 | 6 | 36 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 2.16e-05 | 6 | 36 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | temporal arteritis (is_marker_for) | 3.03e-05 | 7 | 36 | 2 | DOID:13375 (is_marker_for) | |
| Disease | Polysyndactyly | 3.03e-05 | 7 | 36 | 2 | C0265553 | |
| Disease | Scoliosis, unspecified | 4.03e-05 | 8 | 36 | 2 | C0036439 | |
| Disease | Syndactyly | 4.03e-05 | 8 | 36 | 2 | C0039075 | |
| Disease | adverse effect, response to xenobiotic stimulus | 5.17e-05 | 59 | 36 | 3 | EFO_0009658, GO_0009410 | |
| Disease | hemangiopericytoma (is_marker_for) | 5.18e-05 | 9 | 36 | 2 | DOID:264 (is_marker_for) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 9.48e-05 | 12 | 36 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Glioblastoma | 1.24e-04 | 79 | 36 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.48e-04 | 84 | 36 | 3 | C0334588 | |
| Disease | cancer (implicated_via_orthology) | 3.12e-04 | 268 | 36 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 3.38e-04 | 111 | 36 | 3 | C1621958 | |
| Disease | congenital heart disease (is_implicated_in) | 3.93e-04 | 24 | 36 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | sleep quality | 4.04e-04 | 118 | 36 | 3 | EFO_0005272 | |
| Disease | Mammary Carcinoma, Human | 4.18e-04 | 525 | 36 | 5 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.18e-04 | 525 | 36 | 5 | C1257931 | |
| Disease | Mammary Neoplasms | 4.25e-04 | 527 | 36 | 5 | C1458155 | |
| Disease | L lactate dehydrogenase measurement | 4.62e-04 | 26 | 36 | 2 | EFO_0004808 | |
| Disease | Breast Carcinoma | 4.67e-04 | 538 | 36 | 5 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PNGDCDDLGRGSKAC | 266 | A6NCS6 | |
| DGIGDACDNCPQKSN | 401 | P49747 | |
| NPCRNGGSCKDQEDG | 331 | Q9NR61 | |
| SVAGNSQCGDCGQPD | 411 | Q96P50 | |
| QPGETCLNGGKCEAA | 26 | P46531 | |
| ENIDDCPGNNCKNGG | 256 | P46531 | |
| CPGNNCKNGGACVDG | 261 | P46531 | |
| CNEGSNCDTNPVNGK | 381 | P46531 | |
| PHGKLCDGENDCGDN | 2566 | Q9NZR2 | |
| NIDDCLGQPCRNGGT | 636 | Q9Y219 | |
| DKGCDGPNADQCLNC | 701 | P29122 | |
| RGGGPCKQQCRDTGD | 181 | P23142 | |
| PCANGGTCRDGVNDF | 451 | O00548 | |
| GKLCGACGNFDGDQT | 5366 | Q9Y6R7 | |
| KNPCAGGECINNQGS | 496 | P35555 | |
| IQCGDGCDPQGLRDN | 71 | Q9NPF7 | |
| GAEQGELLNPCRCDG | 176 | A6NNE9 | |
| CQDCKLQADDNGDPG | 96 | Q14314 | |
| QACGQLCSGAPGEQD | 476 | Q9Y6C2 | |
| EQAGSPCRNGGQCQD | 136 | Q6UY11 | |
| DNNECGSQPSLCGAK | 2571 | P35556 | |
| DGDQCETSPCQNQGK | 86 | P00742 | |
| NPGRDGKEEACEGTC | 326 | Q9BRP7 | |
| PKGNSSGNDKECCND | 86 | Q8TAA1 | |
| NGNCCGGARNPGDRK | 51 | P78504 | |
| KRCPAGFQGEDCGQE | 716 | O75095 | |
| LGCKQCGGGRDQDEE | 21 | Q9Y6P5 | |
| GGAPCEGDRQELQGC | 2751 | A2VEC9 | |
| EGKCRGCFGSSQNED | 2291 | P25391 | |
| KDDSGGQEANNPNCC | 466 | Q70EK9 | |
| PGACNGSRNSCEGED | 646 | Q13107 | |
| SQQCNGKDDCGDGSD | 541 | Q9Y5Y6 | |
| QEDNKRGPCSNGEAA | 96 | A8MX80 | |
| VAGAPSGCDCKNDAN | 1506 | Q6N022 | |
| SNPNKHGEQCQEDCG | 771 | Q9NY15 | |
| NRSCNQKEGSECPQG | 311 | A0A0J9YWL9 | |
| IDECNDGNNGGCDPN | 371 | P49746 | |
| DGNNGGCDPNSICTN | 376 | P49746 | |
| QEDNKRGPCSNGEAA | 96 | Q8N9G6 | |
| QEDNKRGPCSNGEAA | 96 | A8MUI8 | |
| QEDNKRGPCSNGEAA | 96 | A8MUA0 | |
| AELGADCTCGPQEGN | 296 | Q13395 | |
| PNGSGRNNDCERCSD | 346 | O95405 | |
| NAKEDNCGVCAGDGS | 211 | P82987 | |
| GQVDCDNGSDEQGCP | 91 | P01130 | |
| PRTGEENCNVNNGGC | 351 | O75096 | |
| PAGKNRCGDNNGGCT | 696 | O75096 |